关注
David Rozema
David Rozema
Empirico
在 wisc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
DB Rozema, DL Lewis, DH Wakefield, SC Wong, JJ Klein, PL Roesch, ...
Proceedings of the National Academy of Sciences 104 (32), 12982-12987, 2007
8432007
Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection
CI Wooddell, DB Rozema, M Hossbach, M John, HL Hamilton, Q Chu, ...
Molecular Therapy 21 (5), 973-985, 2013
3662013
Artificial chaperones: protein refolding via sequential use of detergent and cyclodextrin
D Rozema, SH Gellman
Journal of the American Chemical Society 117 (8), 2373-2374, 1995
2881995
Artificial chaperone-assisted refolding of denatured-reduced lysozyme: modulation of the competition between renaturation and aggregation
D Rozema, SH Gellman
Biochemistry 35 (49), 15760-15771, 1996
2791996
Artificial chaperone-assisted refolding of carbonic anhydrase B
D Rozema, SH Gellman
Journal of Biological Chemistry 271 (7), 3478-3487, 1996
2681996
Breaking the bonds: non-viral vectors become chemically dynamic
JA Wolff, DB Rozema
Molecular Therapy 16 (1), 8-15, 2008
2162008
Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules
DB Rozema, K Ekena, DL Lewis, AG Loomis, JA Wolff
Bioconjugate chemistry 14 (1), 51-57, 2003
2142003
Polyconjugates for in vivo delivery of polynucleotides
DB Rozema, JE Hagstrom, J Klein, DL Lewis, SD Monahan, ...
US Patent 8,137,695, 2012
1652012
Artificial chaperone-assisted refolding of citrate synthase
DL Daugherty, D Rozema, PE Hanson, SH Gellman
Journal of Biological Chemistry 273 (51), 33961-33971, 1998
1611998
Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs In Vivo
SC Wong, JJ Klein, HL Hamilton, Q Chu, CL Frey, VS Trubetskoy, ...
Nucleic acid therapeutics 22 (6), 380-390, 2012
1332012
Polyconjugates for in vivo delivery of polynucleotides
DB Rozema, DH Wakefield, DL Lewis, J Klein, S Wong, JA Wolff, ...
US Patent 8,658,211, 2014
1312014
The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities
CE Trueblood, VL Boyartchuk, EA Picologlou, D Rozema, CD Poulter, ...
Molecular and cellular biology 20 (12), 4381-4392, 2000
1242000
Compositions for targeted delivery of siRNA
DB Rozema, DL Lewis, DH Wakefield
US Patent 8,313,772, 2012
1212012
Peptide-based in vivo siRNA delivery system
DB Rozema, DH Wakefield, DL Lewis, JA Wolff, AV Blokhin, JD Benson, ...
US Patent 8,501,930, 2013
1132013
Compositions and methods for drug delivery using pH sensitive molecules
VS Trubetskoy, JE Hagstrom, VG Budker, JA Wolff, DB Rozema, ...
US Patent 6,919,091, 2005
1022005
Delivery of siRNA to cells using polyampholytes
V Trubetskoy, D Rozema, S Monahan, V Budker, J Hagstrom, J Wolff
US Patent App. 10/368,139, 2004
852004
Compositions and methods for drug delivery using pH sensitive molecules
VS Trubetskoy, JE Hagstrom, VG Budker, JA Wolff, DB Rozema, ...
US Patent 7,098,032, 2006
822006
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
P Hadwiger, T Hoffmann, EA Kitas, P Mohr, I Roehl, L Valis, DB Rozema, ...
US Patent 9,249,179, 2016
812016
Intravascular delivery of non-viral nucleic acid
J Hagstrom, J Wolff, S Monahan, D Rozema, V Budker, P Slattum, ...
US Patent App. 10/609,938, 2004
812004
Endosomolytic Modified Poly (Alcohol) and Poly (Amine) Polymers
SD Monahan, L Higgs, DH Wakefield, DB Rozema, JA Wolff, JE Hagstrom
US Patent App. 12/140,736, 2008
752008
系统目前无法执行此操作,请稍后再试。
文章 1–20